For the Inventor, By the Inventor

Enter assignee name

Polifarma S.p.a.

Calculating rank

USPTO Granted Patents = 18

Forward Citations = 139

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Vincenzo Politi (16 out of 19 patents)

Giovanni Di Stazio (16 out of 18 patents)

Giovanna De Luca (16 out of 18 patents)

4. Mario Materazzi (12 out of 13 patents)

5. Andrea Margonelli (4 out of 5 patents)

6. Alessandro Sisto (3 out of 15 patents)

7. Antonio S Verdini (3 out of 35 patents)

8. Silvana D'Alessio (2 out of 3 patents)

9. Antonino Virdia (2 out of 5 patents)

10. Cinzia Piazza (1 out of 2 patents)

11. Giovanna DeLuca (1 out of 1 patent)

12. Giovanni DiStazio (1 out of 1 patent)

13. Vincenzo Polita (1 out of 1 patent)

14. Vencenzo Politi (1 out of 1 patent)

15. Mario Materazzi, Deceased (1 out of 1 patent)

18 patents: Sort by Forward Citations

1. 6057297 - Inhibitor compounds of zinc-dependent metalloproteinases associated with (2000-05-02),

2. 5962459 - Therapeutic active agent for treatment of neuron degenerative diseases (1999-10-05),

3. 5846755 - Method for determining the therapeutic activity of metalloproteinase (1998-12-08),

4. 5736518 - Peptide compounds of (L) amino acids and ring molecules, and (1998-04-07),

5. 5504071 - Compounds with a sequence of three radicals, the central one being .alpha.- (1996-04-02),

6. 5447951 - Method for reducing the level of glucocorticoids in the blood and (1995-09-05),

7. 5210215 - Tryptophane and 3-indolepyruvic acid, methods of production therefor (1993-05-11),

8. 5190948 - Use of uridine in the pharmacological treatment of the peripheral (1993-03-02),

9. 5143903 - Method of treatment with tripeptide pharmaceutical compositions as (1992-09-01),

10. 5091172 - Cosmetic use of 3-indolepyruvic acid (1992-02-25),

11. 5075329 - Use of 3-indolepyruvic acid as a pharmaceutical agent for the inhibition (1991-12-24),

12. 5051404 - Tripeptide compounds having hypotensive activity (1991-09-24),

13. 4960759 - Pharmacological use of uridine in the treatment of nervous disorders (1990-10-02),

14. 4808728 - Production of indolepyruvic acid and the 5-hydroxy derivative thereof (1989-02-28),

15. 4748155 - Pharmacologically active tripeptides and process for their synthesis (1988-05-31),

Company Overview

Polifarma S.p.a. is an Italian pharmaceutical company based in Rome, specializing in the development and manufacturing of a diverse range of pharmaceutical products. The company focuses on innovative solutions in various therapeutic areas, including pain management, oncology, and cardiovascular health. With a commitment to research and development, Polifarma aims to enhance patient care through advanced formulations and high-quality standards, contributing to the healthcare landscape both in Italy and internationally.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

18 Patents

#31 in Rome

#507 in Italy

#34,263 in the World

Polifarma S.p.a.

Forward Citations = 139

16 inventors:

Vincenzo Politi (16 out of 19 patents)

Giovanni Di Stazio (16 out of 18 patents)

Giovanna De Luca (16 out of 18 patents)

4. Mario Materazzi (12 out of 13 patents)

5. Andrea Margonelli (4 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Polifarma S.p.a.. Retrieved from https://idiyas.com/company/polifarma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…